Mulmit

Adaptimmune Therapeutics PLCAdaptimmune Therapeutics PLC

ADAPY US

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2024-12-31178,032,000-68,760,000-70,814,000-0.05
2023-12-3160,281,000-139,741,000-113,871,000-0.09
2022-12-3127,148,000-163,965,000-165,456,000-0.17
2021-12-316,149,000-162,246,000-158,090,000-0.17
2020-12-313,958,000-133,405,000-130,092,000-0.15

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2025-09-02Wood GavinChief Financial Officer96,000
2025-08-28Bertrand William C JRChief Operating Officer207,000
2025-08-18Behbahani Ali14,671,794
2025-08-15Behbahani Ali4,828,206
2025-07-30EcoR1 Capital, LLC27,433,338
2025-07-29EcoR1 Capital, LLC2,687,460
2025-07-28EcoR1 Capital, LLC33,931,740
2025-02-20Bertrand William C JRChief Operating Officer1,612,032
2025-02-20Bertrand William C JRChief Operating Officer1,074,696
2025-02-20Brewer Joanna ElizabethChief Scientific Officer1,612,032
2025-02-20Brewer Joanna ElizabethChief Scientific Officer1,074,696
2025-02-20Lunger JohnChief Patient Supply Officer1,612,032

8-K events

FiledItems
2025-10-20Delisting or listing-standard notice · Regulation FD disclosure · Financial statements and exhibits
2025-09-26Delisting or listing-standard notice
2025-09-12Delisting or listing-standard notice
2025-09-08Officer or director change · Financial statements and exhibits
2025-08-29Officer or director change · Financial statements and exhibits
2025-08-15Officer or director change · Financial statements and exhibits
2025-08-14Delisting or listing-standard notice
2025-08-13Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.